|
1 hit(s) found in 0.10 seconds Search term: VXIMPSPISRVBPZ-NWUMPJBXBM Found by InChIKey (full match)
Please
login
to be able to add spectra, identifiers, links and publications.
|
|
|
ChemSpider ID: |
18023
|
|
Empirical Formula: |
C22H30O3
|
|
Molecular Weight: |
342.4718
|
|
Nominal Mass: |
342
Da
|
|
Average Mass: |
342.4718
Da
|
|
Monoisotopic Mass: |
342.219495
Da
|
|
|
|
Systematic Name: |
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one
|
|
SMILES: |
O=C4\C=C3\C(=C/[C@@H]1[C@H](CC[C@@]2([C@@](O)(C(=O)C)CC[C@@H]12)C)[C@@]3(C)CC4)C
|
|
InChI: |
InChI=1/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1
|
|
InChIKey: |
VXIMPSPISRVBPZ-NWUMPJBXBM
|
|
Std. InChI: |
InChI=1S/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1
|
|
Std. InChIKey: |
VXIMPSPISRVBPZ-NWUMPJBXSA-N
|
Megestrol is a progesterone derivative with antineoplastic properties used in the treatment of advanced carcinoma of the breast and endometrium. When given in relatively high doses, Megestrol can substantially increase appetite in most individuals, even those with advanced cancer. It is also used to boost appetite in individuals with other cancers or HIV/AIDS.
Megestrol acetate oral suspension (a form of Megestrol) is used primarily as an appetite enhancer. The method of appetite enhancement is not known, but it can cause high blood sugar.
Currently, it is manufactured under the trade name Megace.
Little is known about the drug's chemical interactions. Doses range from 40 mg three times a day, 30 minutes before meals, to 800 mg once a day. Side effects may include diarrhea, rash, and impotence. Males may have some feminizing effects such as gynecomastia (breast development). It is a category X U.S. Food and Drug Administration drug, which means cannot be used in pregnancy as it crosses the placenta and malignantly affects the fetus.
It may cause adrenal insufficiency.
Read more... or Edit at Wikipedia...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
222-628-6
[EINECS/ELINCS]
3562-63-8
[RN]
megestrol
[Wiki]
Megestrolo [DCIT]
megestrolum
[Latin]
Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-
DMAP
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione
9005-80-5
[RN]
More...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
|
ACD/LogP: |
3.06
|
# of Rule of 5 Violations: |
0
|
|
ACD/LogD (pH 5.5): |
3.06
|
ACD/LogD (pH 7.4): |
3.06
|
|
ACD/BCF (pH 5.5): |
124.95
|
ACD/BCF (pH 7.4): |
124.95
|
|
ACD/KOC (pH 5.5): |
1102.7
|
ACD/KOC (pH 7.4): |
1102.69
|
|
#H bond acceptors: |
3
|
#H bond donors: |
1
|
|
#Freely Rotating Bonds: |
2
|
Polar Surface Area: |
43.37
Å2
|
|
Index of Refraction: |
1.569
|
Molar Refractivity: |
96.83
cm3
|
|
Molar Volume: |
295.4
cm3
|
Polarizability: |
38.38
10-24cm3
|
|
Surface Tension: |
46.4
dyne/cm
|
Density: |
1.15
g/cm3
|
|
Flash Point: |
270.5
°C
|
Enthalpy of Vaporization: |
88.55
kJ/mol
|
|
Boiling Point: |
500.4
°C at 760 mmHg
|
Vapour Pressure: |
4.15E-12
mmHg at 25°C
|
Log Octanol-Water Partition Coef (SRC):
Log Kow (KOWWIN v1.67 estimate) = 3.41
Boiling Pt, Melting Pt, Vapor Pressure Estimations (MPBPWIN v1.42):
Boiling Pt (deg C): 436.48 (Adapted Stein & Brown method)
Melting Pt (deg C): 182.93 (Mean or Weighted MP)
VP(mm Hg,25 deg C): 3.48E-010 (Modified Grain method)
Subcooled liquid VP: 1.54E-008 mm Hg (25 deg C, Mod-Grain method)
Water Solubility Estimate from Log Kow (WSKOW v1.41):
Water Solubility at 25 deg C (mg/L): 27.02
log Kow used: 3.41 (estimated)
no-melting pt equation used
Water Sol Estimate from Fragments:
Wat Sol (v1.01 est) = 5.9991 mg/L
ECOSAR Class Program (ECOSAR v0.99h):
Class(es) found:
Vinyl/Allyl Ketones
Henrys Law Constant (25 deg C) [HENRYWIN v3.10]:
Bond Method : 1.14E-008 atm-m3/mole
Group Method: Incomplete
Henrys LC [VP/WSol estimate using EPI values]: 5.804E-012 atm-m3/mole
Log Octanol-Air Partition Coefficient (25 deg C) [KOAWIN v1.10]:
Log Kow used: 3.41 (KowWin est)
Log Kaw used: -6.332 (HenryWin est)
Log Koa (KOAWIN v1.10 estimate): 9.742
Log Koa (experimental database): None
Probability of Rapid Biodegradation (BIOWIN v4.10):
Biowin1 (Linear Model) : 0.0464
Biowin2 (Non-Linear Model) : 0.0004
Expert Survey Biodegradation Results:
Biowin3 (Ultimate Survey Model): 1.7610 (months )
Biowin4 (Primary Survey Model) : 2.8489 (weeks )
MITI Biodegradation Probability:
Biowin5 (MITI Linear Model) : 0.3013
Biowin6 (MITI Non-Linear Model): 0.0345
Anaerobic Biodegradation Probability:
Biowin7 (Anaerobic Linear Model): -2.0175
Ready Biodegradability Prediction: NO
Hydrocarbon Biodegradation (BioHCwin v1.01):
Structure incompatible with current estimation method!
Sorption to aerosols (25 Dec C)[AEROWIN v1.00]:
Vapor pressure (liquid/subcooled): 2.05E-006 Pa (1.54E-008 mm Hg)
Log Koa (Koawin est ): 9.742
Kp (particle/gas partition coef. (m3/ug)):
Mackay model : 1.46
Octanol/air (Koa) model: 0.00136
Fraction sorbed to airborne particulates (phi):
Junge-Pankow model : 0.981
Mackay model : 0.992
Octanol/air (Koa) model: 0.0978
Atmospheric Oxidation (25 deg C) [AopWin v1.92]:
Hydroxyl Radicals Reaction:
OVERALL OH Rate Constant = 255.5080 E-12 cm3/molecule-sec
Half-Life = 0.042 Days (12-hr day; 1.5E6 OH/cm3)
Half-Life = 0.502 Hrs
Ozone Reaction:
OVERALL Ozone Rate Constant = 34.222500 E-17 cm3/molecule-sec
Half-Life = 0.033 Days (at 7E11 mol/cm3)
Half-Life = 48.221 Min
Fraction sorbed to airborne particulates (phi): 0.986 (Junge,Mackay)
Note: the sorbed fraction may be resistant to atmospheric oxidation
Soil Adsorption Coefficient (PCKOCWIN v1.66):
Koc : 622.2
Log Koc: 2.794
Aqueous Base/Acid-Catalyzed Hydrolysis (25 deg C) [HYDROWIN v1.67]:
Rate constants can NOT be estimated for this structure!
Bioaccumulation Estimates from Log Kow (BCFWIN v2.17):
Log BCF from regression-based method = 1.929 (BCF = 84.91)
log Kow used: 3.41 (estimated)
Volatilization from Water:
Henry LC: 1.14E-008 atm-m3/mole (estimated by Bond SAR Method)
Half-Life from Model River: 9.505E+004 hours (3960 days)
Half-Life from Model Lake : 1.037E+006 hours (4.321E+004 days)
Removal In Wastewater Treatment:
Total removal: 11.14 percent
Total biodegradation: 0.17 percent
Total sludge adsorption: 10.97 percent
Total to Air: 0.00 percent
(using 10000 hr Bio P,A,S)
Level III Fugacity Model:
Mass Amount Half-Life Emissions
(percent) (hr) (kg/hr)
Air 0.0131 0.447 1000
Water 14.6 1.44e+003 1000
Soil 84.4 2.88e+003 1000
Sediment 1 1.3e+004 0
Persistence Time: 1.6e+003 hr
Descriptors:
0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 1, 2, 27, 0, 0, 2, 0, 0, 2, 2, 4, 0, 0, 0
| Category | Target | PDB Code | LASSO Score |
| Nuclear Hormone Receptors | MR, mineralocorticoid receptor | 2aa2 | 0.88 |
| Nuclear Hormone Receptors | AR, androgen receptor | 1xq2 | 0.42 |
| Nuclear Hormone Receptors | ER, estrogen receptor; agonist | 1l2i | 0.40 |
| Nuclear Hormone Receptors | PR, progesterone receptor | 1sr7 | 0.24 |
| Nuclear Hormone Receptors | GR, glucocorticoid receptor | 1m2z | 0.10 |
| Metalloenzymes | ACE, angiotensin-converting enzyme | 1o86 | 0.03 |
| Nuclear Hormone Receptors | RXRa, retinoic X receptor R | 1mvc | 0.03 |
| Nuclear Hormone Receptors | PPARg, peroxisome proliferator activated receptor | 1fm9 | 0.02 |
| Kinases | PDGFrb, platelet derived growth factor receptor kinase | N/A | 0.02 |
| Kinases | SRC, tyrosine kinase SRC | 2src | 0.01 |
| Serine Proteases | Thrombin | 1ba8 | 0.01 |
| Other Enzymes | HMGR, hydroxymethylglutaryl-CoA reductase | 1hw8 | 0.01 |
| Other Enzymes | HIVPR, HIV protease | 1hpx | 0.01 |
| Metalloenzymes | PDE5, phosphodiesterase 5 | 1xp0 | 0.01 |
| Other Enzymes | PARP, poly(ADP-ribose) polymerase | 1efy | 0.01 |
| Other Enzymes | PNP, purine nucleoside phosphorylase | 1b8o | 0.00 |
| Folate Enzymes | DHFR, dihydrofolate reductase | 3dfr | 0.00 |
| Other Enzymes | AmpC, AmpC beta-lactamase | 1xgj | 0.00 |
| Other Enzymes | HIVRT, HIV reverse transcriptase | 1rt1 | 0.00 |
| Kinases | HSP90, human heat shock protein 90 | 1uy6 | 0.00 |
| Other Enzymes | NA, neuraminidase | 1a4g | 0.00 |
| Serine Proteases | Trypsin | 1bju | 0.00 |
| Kinases | VEGFr2, vascular endothelial growth factor receptor | 1vr2 | 0.00 |
| Other Enzymes | GPB, glycogen phosphorylase | 1a8i | 0.00 |
| Other Enzymes | SAHH, S-adenosyl-homocysteine hydrolase | 1a7a | 0.00 |
| Kinases | FGFr1, fibroblast growth factor receptor kinase | 1agw | 0.00 |
| Other Enzymes | COX-2, cyclooxygenase-2 | 1cx2 | 0.00 |
| Metalloenzymes | COMT, catechol O-methyltransferase | 1h1d | 0.00 |
| Kinases | CDK2, cyclindependent kinase 2 | 1ckp | 0.00 |
| Kinases | TK, thymidine kinase | 1kim | 0.00 |
| Kinases | P38 MAP, P38 mitogen activated protein | 1kv2 | 0.00 |
| Other Enzymes | AChE, acetylcholinesterase | 1eve | 0.00 |
| Folate Enzymes | GART, glycinamide ribonucleotide transformylase | 1c2t | 0.00 |
| Serine Proteases | FXa, factor Xa | 1f0r | 0.00 |
| Metalloenzymes | ADA, adenosine deaminase | 1stw | 0.00 |
| Kinases | EGFr, epidermal growth factor receptor | 1m17 | 0.00 |
|
|